RE: Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer

J Natl Cancer Inst. 2015 Jun 4;107(8):djv149. doi: 10.1093/jnci/djv149. Print 2015 Aug.

Authors

Margaret Lee¹, Peter Gibbs²

Affiliations

¹ Walter and Eliza Hall Institute of Medical Research (PG), Department of Medical Oncology (ML), The Royal Melbourne Hospital, Kensington, Vic, Australia. margaret.mwlee@gmail.com.
² Walter and Eliza Hall Institute of Medical Research (PG), Department of Medical Oncology (ML), The Royal Melbourne Hospital, Kensington, Vic, Australia.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Aspirin / administration & dosage*
Colonic Neoplasms / pathology*
Colonic Neoplasms / prevention & control*
Cyclooxygenase 2 Inhibitors / administration & dosage*
Female
Humans
Male
Neoplasm Recurrence, Local / prevention & control*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Aspirin